 
        
        - •Лекция 1 Лекция 1
- •Edward Jenner "the father of immunology"
- •smallpox vaccine, the world's first vaccine.
- •Louis Pasteur
- •ОпределениеОпределениеиммунологиииммунологии
- •Главная функция иммунной системы – распознавание «свой-чужой»
- •Эволюция иммунных механизмов
- •ОсновныеОсновныеэлементыэлементыиммуннойиммуннойсистемсистем
- •ПроисхождениеПроисхождениеклетокклетокиммуннойиммуннойсистесист
- •ПроисхождениеПроисхождениеклетокклетокиммуннойиммуннойсистесист
- •сновныеновные лимфоидныелимфоидныеорганыорганыииобразованобразован
- •РециркуляцияРециркуляциялимфоцитовлимфоцитовии антигенантиген--презентирующихпрезентирующихклетокклеток
- •Поверхностные маркеры
- •ЕстественныеЕстественныеии адаптивныеадаптивные иммунныеиммунныемеханизмымеханизмы
- •ФагоцитарныеФагоцитарныеклеткиклетки..СистемаСистема мононуклеарныхмононуклеарныхфагоцитовфагоцитов
- •Функции комплемента в антибактериальном иммунитете
- •ФагоцитозФагоцитоз
- •ФагоцитозФагоцитоз
- •ВзаимодействиеВзаимодействиемеждумеждулимфоцитамилимфоцитами иифагоцитамифагоцитами
- •Клеточный иммунный ответ
- •Суперсемейство иммуноглобулинов – основа системы распознования «свой-чужой»
- •Участки антигена, распознаваемые молекулами Участки антигена, распознаваемые молекулами главного комплекса гистосовместимости (МНС) и
- •Тримолекулярный комплекс
- •РаспознаваниеРаспознаваниеиипереработкапереработкаантигенантиген
- •Гуморальный иммунный ответ
- •КлональнаяКлональнаяселекцияселекцияВВ--клетокклеток
- •СтроениеСтроениеIgGIgG
- •Взаимодействие антигена и антитела
- •ОсновныеОсновныеформыформыпатологиипатологиииммуннойиммуннойсиси
- •ВВ--клеточныйклеточныйответответнанасобственныесобственные илииличужеродныечужеродныеантигеныантигены
- •ПерекрестноПерекрестно--реагирующиереагирующиеантигеныантигены индуцируютиндуцируютпоявлениепоявление аутоиммунныхаутоиммунныхТхТх--клетокклеток
- •ИндукцияИндукциясинтезасинтезааутоантителаутоантител перекрестноперекрестно--реагирующимиреагирующимиантигенамиантигенами
- •Лекция 2 Лекция 2
- •Insects and infections
- •Induction of antimicrobial activity by immune challenge
- •E. Metchnikow
- •ФагоцитарныеФагоцитарныеклеткиклетки..СистемаСистема мононуклеарныхмононуклеарныхфагоцитовфагоцитов
- •ХемотаксисХемотаксис
- •ХемотаксисХемотаксис
- •ХемокиныХемокины
- •ХемотаксисХемотаксис
- •ФагоцитозФагоцитоз
- •ФагоцитозФагоцитоз
- •Jules Hoffmann
- •drosophila
- •“Scavenger“ScavengerReceptors”Receptors”
- •СистемаСистемаTLRTLR
- •Toll
- •imd and Toll mutants are immunocompromised
- •How is infection sensed in insects?
- •The mutant semmelweis reveals
- •Sensing Gram-negative infections in Drosophila
- •Peptidoglycan structure Lys-type
- •Peptidoglycan structure
- •TCT/PGRP-LC complex
- •Drosophila recognition proteins for microbial structures
- •Fungi Yeast
- •Prizes won for discoveries in the field of TLRs
- •Mammalian TLR signalling pathways.
- •Innate immunity: sensing and signalling
- •Innate immunity and virus infection
- •Главные функции комплемента в воспалительном про
- •КлассическийКлассическийииальтернативныйальтернативный путипутиактивацииактивациисистемысистемы комплементакомплемента
 
How is infection sensed in insects?
| Fungi Yeast | Gram positive | Gram negative | 
| 
 | bacteria | bacteria | 
| 
 | 
 | 
| ? | ? | ? | 
| 
 | Spz | |
| Toll | 
 | Toll-2? | 
| 
 | 
 | IMD (RIP) | 
| Dif (NF- B ) | Relish (NF- B ) | |
| Drosomycin | Diptericin | 
 
| The mutant semmelweis reveals | 
 | ||||||||||
| differences in the sensing of bacteria | |||||||||||
| 
 | 
 | 
 | and fungi | 
 | 
 | 
 | 
 | 
 | 
 | ||
| Streptococcus faecalis | 
 | Beauveria bassiana | 
 | ||||||||
| 100 | (Gram +) | 
 | Survival rate (%) | 100 | 
 | (Fungus) | 
 | 
 | |||
| 
 | 
 | wt | 
 | 
 | 
 | 
 | wt | 
 | |||
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | |||
| 50 | 
 | 
 | 
 | 50 | 
 | 
 | 
 | 
 | 
 | 
 | |
| Survivalrate(%) | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | |
| 
 | 
 | Seml | 
 | 
 | 
 | 
 | 
 | 
 | Seml | ||
| 0 0 | 12 | 24 | 36 | 
 | 0 0 | 1 | 2 | 3 | 4 | 5 | 6 | 
| 
 | Time p.i. (h) | 
 | 
 | 
 | 
 | Time p.i. (d) | 
 | ||||
Michel et al Nature (20
 
| 
 | The PeptidoGlycan Recognition Protein | |||||||||||||||||||||||||||||||||||||||||
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | (PGRP) family (drosophila) | |||||||||||||||||||||||||||||||||||
| 
 | SA | 
 | 
 | 
 | Semmelweis | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | ||||||||||||||||||||||
| 
 | 
 | 
 | 
 | 
 | ||||||||||||||||||||||||||||||||||||||
| 
 | 203 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | ||||||||||||||||||||||||||
| 
 | SB1 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 190 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | ||||
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | |||||||
| 
 | SB2 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 182 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | |||||
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | ||||||||
| 
 | SC1a | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 185 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | |||||||
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | |||||||||
| 
 | SC1b | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | |||||
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 185 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | ||||||||
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | |||||||||
| 
 | SC2 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 184 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | |||||||||
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | |||||||||||||
| 
 | SD | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 186 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | |||||||||
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | ||||||
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | ||||||||||||
| 
 | LA | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 280 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | |
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | |||||||||||||
| 
 | LB | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 215 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | ||||||||||||
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | ||||
| 
 | LC | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 520 | 
 | ||||||||||||||||||||||
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | |||
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
| 
 | LD | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 505 | 
 | ||||||||||||||||||||||||||
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | ||||
| 
 | LE | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 345 | 
 | 
 | 
 | 
 | 
 | 
 | 
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | ||||||||
| 
 | LF | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 337 | 
 | 
 | 
 | 
 | 
 | 
 | |
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | |||||||||
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
| Signal peptide | PGRP domain with/without amidase | 
| Transmembrane domain | activity | 
| 
 | 
 
Sensing Gram-negative infections in Drosophila
Survival rate
infection by Enterobacter cloacae (Gram-)
100
PGRP-SA -/-
50
PGRP-LC -/-
| 12 | 
 | 24 | 36 | 
 | 48 | 
| 
 | 
 | Time (h) | 
 | 
 | 
 | 
| E. cloacae: - | + + + | 
 | 
 | ||
| 
 | 
 | 
 | 
 | 
 | 
 | 
| Diptericin | 
 | 
 | 
 | 
 | |
| 
 | 
 | 
 | 
 | ||
| 
 | 
 | 
 | - | 
 | |
| 
 | wt | wt SA -/-LC -/ | 
 | ||
Gottar et al Nature (2
 
Peptidoglycan structure Lys-type
(most Gram+)
| Glycan strand | 
 | 
 | 
 | 
 | 
 | |
| GlcNAc | MurNAc | GlcNAc | MurNAc | GlcNAc | MurNAc | |
| 
 | L-Ala | 
 | 
 | L-Ala | 
 | L-Ala | 
| 
 | D-Glu | 
 | 
 | D-Glu | 
 | D-Glu | 
| Short peptide L-Lys | (Gly) D-Ala | 
 | 
 | L-Lys | ||
| bridge | D-Ala | 
 | L-Lys | 
 | 
 | D-Ala | 
| 
 | 
 | 
 | D-Glu | |||
| 
 | 
 | 
 | D-Glu | 
 | 
 | |
| 
 | 
 | 
 | L-Ala | 
 | L-Ala | 
 | 
| Glycan strand | 
 | MurNAc | GlcNAc | MurNAc | 
 | |
| 
 | GlcNAc | 
 | ||||
 
Peptidoglycan structure
Glycan strand
| GlcNAc | MurNAc | GlcNAc | MurNAc | 
| 
 | L-Ala | 
 | 
 | 
 | 
 | 
 | L-Ala | |||||
| 
 | D- | 
 | Glu | 
 | 
 | 
 | 
 | 
 | D- | 
 | Glu | |
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | |||||
| Short peptide DAP | 
 | (Gly) | 
 | D-Ala | 
 | 
 | 
 | |||||
| 
 | 
 | 
 | 
 | |||||||||
| 
 | 
 | 
 | ||||||||||
| 
 | 
 | 
 | 
 | 
 | ||||||||
| bridge | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | |
| D-Ala | 
 | 
 | DAP | 
 | 
 | 
 | ||||||
| 
 | 
 | 
 | 
 | 
 | 
 | |||||||
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | D- | 
 | Glu | 
 | 
 | 
 | 
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | |||
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | L-Ala | 
 | 
 | 
 | ||
| Glycan strand | 
 | MurNAc | GlcNAc | |||||||||
| 
 | GlcNAc | |||||||||||
DAP-type
(Gram-)
TCT
GlcNAc MurNAc
L-Ala
D-Glu
DAP
D-Ala
D-Glu
L-Ala
MurNAc
 
TCT/PGRP-LC complex
DAP
From Chang et al (2006), Science 311: 17
 
Drosophila recognition proteins for microbial structures
Signal PGRP domain peptide
| PGRP-SA | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | (semmelweis) | PGN (Ly | 
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | |||
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | |||
| 
 | 
 | 
 | 180203 | 
 | 
 | |||||
| 
 | 27 38 | 
 | Michel et al (2001) Nat | |||||||
| 
 | 
 | 
 | 
 | 
 | Transmembrane | 
 | ||||
| PGRP-LC | 
 | PGRP domain | 
 | |||||||
| 
 | domain | 
 | ||||||||
| 295 317 | 353 | PGN (DA | 
| 498 520 | 
Gottar et al (2002) Nat
GNBP-1
GNBP-3
| GNBP homology | 
 | 
 | 
 | -glucanase | 
 | 
 | 
 | ||||||||
| 
 | 
 | 
 | 
 | 
 | domain | 
 | 
 | 
 | domain | 
 | 
 | PGN (Ly | |||
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | |
| 
 | 
 | 19 | 117 | 194 | 
 | 447 | 492 | ||||||||
| GNBP homology | 
 | 
 | 
 | -glucanase | Gobert et al (2003) Scie | ||||||||||
| 
 | 
 | 
 | 
 | 
 | 
 | ||||||||||
| 
 | 
 | 
 | 
 | 
 | domain | 
 | 
 | 
 | domain | 
 | 
 | - ,3 gluc | |||
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | |
| 
 | 26 | 121 | 242 | 466 | 492 | ||||||||||
Gottar et al (2006) C
 
| Fungi Yeast | Gram positive Gram negative | Virus | |||
| 
 | 
 | bacteria | bacteria | 
 | |
| -glucansl | PGRP-SD | Lys-PGN | DAP-PGN | 
 | |
| 
 | PGRP-SA | 
 | 
 | 
 | |
| Microbial | GNBP-3 | 
 | 
 | 
 | 
 | 
| 
 | 
 | 
 | 
 | 
 | |
| protease | 
 | GNBP- | 
 | 
 | |
| s | 
 | 
 | 
 | 
 | ? | 
| 
 | Spaetzle | Toll | PGRP-LC | 
 | |
| 
 | 
 | 
 | |||
| MyD88 | IMD (RIP) | ? | 
| 
 | ||
| 
 | Relish (NF- B ) | 
 | 
| Dif (NF- B ) | 
 | 
 | 
| Drosomycin | Diptericin | ? | 
Ferrandon et al (2007) Nat Rev Im
 
| 988 | IL- R is cloned. | 
| 989 | Charles Janeway proposes the concept of pattern-recognition | 
| 990 | receptors. | 
| CD14 and LPS-binding protein are identified as components of the | |
| 99 | LPS receptor complex. | 
| Sequence similarity between Toll and IL-1R1 identified | |
| 993– 996 | Pathogen-specific immune signalling found to involve induction of | 
| 
 | antimicrobial peptides by members of the NF-κB family in Drosophila | 
| 994 | melanogaster. | 
| Plant protein N is shown to be involved in disease resistance and to | |
| 996 | have a TIR domain that is similar to Toll and IL-1R1. | 
| The Toll pathway is shown to regulate the antifungal response in D. | |
| 997 | melanogaster. | 
| The first human homologue of Toll receptor is cloned (hToll; later | |
| 
 | renamed TLR4). | 
| 998 | A role for MYD88 in IL-1 receptor signalling is identified. | 
| Four further human TLRs are identified. | |
| 999 | TLR4 is identified as the signalling receptor for LPS. | 
| LPS signalling is found to require MYD88. | |
| 
 | The requirement of MD2 for TLR4 responsiveness to LPS is identified. | 
| 2000-2002 | Ligands for TLR2- heterodimeric complexes are identified | 
| 
 | Viral antagonists of TLRs are identified. | 
| 200 | TLR9 is characterized as the receptor for CpG-DNA. | 
| The first TLR that recognizes viral components is identified (TLR3). | |
| 
 | Flagellin is identified as a ligand for TLR5. | 
| 2002 | MAL (also known as TIRAP) is discovered. | 
| TRIF is discovered. | |
| 2002-2009 | Endogenous ligands for TLRs are identified. | 
| 2003 | TRAM is discovered. | 
| 2004 | TLR7 and TLR8 are reported to recognize viral ssRNA. | 
| 2006 | The first function for mammalian SARM1 (a regulator of TRIF) is | 
| 2007-2009 | reported. | 
| Structures of several TLR–ligand complexes (including TLR4, TLR2– | |
| 
 | TLR1, TLR2–TLR6 and TLR3) are solved. | 
